(2025). Correction to Supporting Information for Melo et al., Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2501333122